REVIEW 2 cited by
AUTOCT: Automating Interpretable Clinical Trial Prediction with LLM Agents
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
AUTOCT: Automating Interpretable Clinical Trial Prediction with LLM Agents
read the original abstract
Clinical trials are critical for advancing medical treatments but remain prohibitively expensive and time-consuming. Accurate prediction of clinical trial outcomes can significantly reduce research and development costs and accelerate drug discovery. While recent deep learning models have shown promise by leveraging unstructured data, their black-box nature, lack of interpretability, and vulnerability to label leakage limit their practical use in high-stakes biomedical contexts. In this work, we propose AutoCT, a novel framework that combines the reasoning capabilities of large language models with the explainability of classical machine learning. AutoCT autonomously generates, evaluates, and refines tabular features based on public information without human input. Our method uses Monte Carlo Tree Search to iteratively optimize predictive performance. Experimental results show that AutoCT performs on par with or better than SOTA methods on clinical trial prediction tasks within only a limited number of self-refinement iterations, establishing a new paradigm for scalable, interpretable, and cost-efficient clinical trial prediction.
Forward citations
Cited by 2 Pith papers
-
Aligning Clinical Needs and AI Capabilities: A Survey on LLMs for Medical Reasoning
A dual clinical-computational taxonomy for medical LLM reasoning plus a five-level 5k-sample benchmark showing specialists excel at diagnosis and general models at decision support/dialogue.
-
ClinicalReTrial: Clinical Trial Redesign with Self-Evolving Agents
ClinicalReTrial is a closed-loop multi-agent system that redesigns textual clinical trial protocols to raise predicted success probability by 5.7% on average while costing $0.12 per trial.
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.